Yoland Antill – Projects — Monash University

View Scopus Profile

EmailYoland.Antillmonashedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

4 Active

4 results

Active

A Phase 3, Randomized, Open-Label, Multicenter Trial of ARV-471 (PF-07850327) vs Fulvestrant in Participants with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Whose Disease Progressed After Prior Endocrine Based Treatment for Advanced Disease (VERITAC-2)
Antill, Y.
23/05/23 → 23/05/25
Project: Research
The GLORIA study: A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High Risk, Early-Stage Globo H-Positive Triple Negative Breast Cancer
Antill, Y.
9/03/23 → 8/03/25
Project: Research
A phase 3, randomised, double-blind study of Trilaciclib or placebo in patients receiving first or second line Gemcitabine and Carboplatin chemotherapy for locally advanced unresectable or metastatic triple-negative breast cancer [G1T28-208] [PRESERVE 2].
Antill, Y. & Lai, L. H.
25/11/21 → 31/12/24
Project: Research
A Phase 1b/III study of Ipatasertib plus Palbociclib and Fulvestrant versus placebo plus Palbociclib and Fulvestrant in hormone receptor positive and Her2 negative locally advanced unresectable or metastatic breast cancer [Ipatunity150] [CO41012]
Antill, Y., Baker, E. & Thompson, K.
13/02/20 → 31/12/25
Project: Research